Equibles does not estimate personal net worth.
The proxy statement of Rocket Pharmaceuticals, Inc. reports total compensation of $2,364,309 for Jonathan Schwartz in fiscal 2024, including a base salary of $454,200. Disclosed compensation is on record for 7 fiscal years. Jonathan Schwartz has spoken on 1 investor event across 1 company, most recently for Rocket Pharmaceuticals, Inc. on March 27, 2026. Rocket Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rocket Pharmaceuticals, Inc. includes Gaurav Shah (CEO and Board Member), Aaron Ondrey (CFO), Carlos Garcia-Parada (CFO) and 7 others.
“Creslati is an autologous hematopoietic stem cell-based gene therapy indicated for the treatment of pediatric patients with severe LAD1 due to biallelic variants in the ITGB2 gene who do not have an available human leukocyte antigen-matched sibling donor for allogeneic hematopoietic stem cell transplant.”
Proxy statement
Start not stated–present
Last confirmed April 6, 2026
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Medical and Gene Therapy Officer | $454,200 | $2,364,309 |
| 2023 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Medical and Gene Therapy Officer | $447,433 | $3,157,844 |
| 2022 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Medical and Gene Therapy Officer | $434,600 | $2,532,457 |
| 2021 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Medical and Gene Therapy Officer | $410,000 | $1,881,845 |
| 2020 | Rocket Pharmaceuticals, Inc. (RCKT) | M.D., SVP and Chief Medical Officer | $395,000 | $1,870,733 |
| 2019 | Rocket Pharmaceuticals, Inc. (RCKT) | M.D., SVP and Chief Medical Officer | $375,000 | $1,475,675 |
| 2018 | Rocket Pharmaceuticals, Inc. (RCKT) | M.D., SVP and Chief Medical Officer | $359,820 | $1,356,675 |
